Perl M, Herfeld K, Harrer DC, Höpting M, Schweiger M, Sterz U, Knödler L, Heimerl S, Hansmann L, Herr W, Poeck H, Wolff D, Edinger M, Hart C, Fante MA. Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies. haematol [Internet]. 2024Sep.1 [cited 2024Nov.8];109(9):2969-77. Available from: https://haematologica.org/article/view/haematol.2023.284564